» Articles » PMID: 29614121

Dominant Serotype Distribution and Antimicrobial Resistance Profile of Shigella Spp. in Xinjiang, China

Overview
Journal PLoS One
Date 2018 Apr 4
PMID 29614121
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Shigella represents one of the major diarrhea-inducing pathogens threatening public health, but its prevalence and antimicrobial resistance profile in Xinjiang Uygur Autonomous region, China, remains unclear. We conducted comprehensive investigation of Shigella serotype distribution and antimicrobial resistance pattern in Xinjiang, identifying 458 Shigella isolates between 2008 to 2014. Shigella flexneri was identified as predominant species, and several S. flexneri serotypes were isolated, including atypical serotypes 1c, 2c, and 4s. Dominant S. flexneri serotypes were 2a, 1b, 2b, and Xv, different from those generally dominant in China. A hybrid serotype pattern was observed, which included the major Chinese serotypes (2a, Xv) and those predominant in Pakistan (1b, 2b). Shigella sonnei was shown to have a lower frequency compared with that generally observed in China, but an increasing trend of infections associated with this pathogen was observed. Furthermore, a high frequency of drug resistance and different Shigella antimicrobial resistance patterns were demonstrated as well, including very severe resistance phenotypes, such as multidrug resistance and resistance to frontline antibiotics. Seventy-five cephalosporin-resistant Shigella isolates were frequently identified with the resistance determinants that can undergo horizontal transfer, such as blaOXA, blaTEM, blaCTX-M, and integrons, facilitating the development of cephalosporin resistance among Shigella subtypes. Additionally, genetic analyses demonstrated that all 86 quinolone-resistant S. flexneri isolates possess 3-4 mutation sites in quinolone resistance-determining regions, primarily contributing to their resistance to quinolone. However, S. sonnei isolates were not shown to be quinolone resistant. Co-resistance to cephalosporins and quinolones was detected in 17 S. flexneri isolates, and these isolates were additionally multidrug resistant and carried β-lactamase genes and quinolone-resistance determinants. As is demonstrated in this study, dominant serotypes of Shigella were distributed in unique trend with dangerous drug resistance patterns. Novel strategies are urgently required to prevent the development of drug resistance among diarrhea-inducing pathogens.

Citing Articles

Prevalence of plasmid-mediated quinolone resistance genes and biofilm formation in different species of quinolone-resistant clinical Shigella isolates: a cross-sectional study.

Al-Khafaji N, Almjalawi B, Ewadh R, Al-Dahmoshi H, Abed S, Nasrolahi A Eur J Med Res. 2024; 29(1):419.

PMID: 39143645 PMC: 11323402. DOI: 10.1186/s40001-024-02007-y.


The relationship between integrons, antibiotic resistance genes and SXT resistance in strains.

Peng C, Yao M, Liu J, Zhang Q, Yuan G, Ma Q Am J Transl Res. 2024; 16(5):1925-1934.

PMID: 38883348 PMC: 11170600. DOI: 10.62347/SNRQ6766.


Prevalence and changing antimicrobial resistance profiles of Shigella spp. isolated from diarrheal patients in Kolkata during 2011-2019.

Bose P, Chowdhury G, Halder G, Ghosh D, Deb A, Kitahara K PLoS Negl Trop Dis. 2024; 18(2):e0011964.

PMID: 38377151 PMC: 10906866. DOI: 10.1371/journal.pntd.0011964.


Prevalence of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Species in Asia: A Systematic Review and Meta-Analysis.

Salleh M, Nik Zuraina N, Hajissa K, Ilias M, Singh K, Deris Z Antibiotics (Basel). 2022; 11(11).

PMID: 36421297 PMC: 9687025. DOI: 10.3390/antibiotics11111653.


Antimicrobial Resistance of Shigella flexneri in Pakistani Pediatric Population Reveals an Increased Trend of Third-Generation Cephalosporin Resistance.

Nisa I, Haroon M, Driessen A, Nijland J, Rahman H, Yasin N Curr Microbiol. 2022; 79(4):118.

PMID: 35220467 DOI: 10.1007/s00284-022-02805-9.


References
1.
Kotloff K, Winickoff J, Ivanoff B, Clemens J, Swerdlow D, Sansonetti P . Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999; 77(8):651-66. PMC: 2557719. View

2.
Mitsuhashi S, Harada K, Hashimoto H, EGAWA R . On the drug-resistance of enteric bacteria. 4. Drug-resistance of Shigella prevalent in Japan. Jpn J Exp Med. 1961; 31:47-52. View

3.
Parsot C . Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors. FEMS Microbiol Lett. 2005; 252(1):11-8. DOI: 10.1016/j.femsle.2005.08.046. View

4.
Pazhani G, Ramamurthy T, Mitra U, Bhattacharya S, Niyogi S . Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect. 2005; 133(6):1089-95. PMC: 2870343. DOI: 10.1017/S0950268805004498. View

5.
Pan J, Ye R, Meng D, Zhang W, Wang H, Liu K . Molecular characteristics of class 1 and class 2 integrons and their relationships to antibiotic resistance in clinical isolates of Shigella sonnei and Shigella flexneri. J Antimicrob Chemother. 2006; 58(2):288-96. DOI: 10.1093/jac/dkl228. View